5 mins | 30 mins | Hourly | Daily | Weekly |
---|---|---|---|---|
SELL | SELL | SELL | SELL | SELL |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MA5 | 1.99▼ | 1.99▼ | 1.99▼ | 1.99▼ | 1.96▲ |
MA10 | 1.99▼ | 1.99▼ | 1.99▼ | 2.06▼ | 5.22▼ |
MA20 | 2.01▼ | 2.01▼ | 2.02▼ | 2.01▼ | 7.88▼ |
MA50 | 2.08▼ | 2.10▼ | 2.10▼ | 6.24▼ | 3.55▼ |
MA100 | 2.06▼ | 2.07▼ | 2.11▼ | 7.60▼ | 2.09▼ |
MA200 | 2.21▼ | 5.70▼ | 7.11▼ | 4.09▼ | N/A |
5 mins | 30 mins | Hourly | Daily | Weekly | |
---|---|---|---|---|---|
MACD | 0.002▲ | 0.002▲ | 0.003▲ | 0.321▲ | -1.301▼ |
RSI | 42.993▼ | 42.570▼ | 42.846▼ | 31.492▼ | 40.685▼ |
STOCH | 46.491 | 46.491 | 46.491 | 18.757▼ | 1.953▼ |
WILL %R | -78.947▼ | -78.947▼ | -78.947▼ | -86.925▼ | -97.678▼ |
CCI | -82.133 | -91.252 | -92.572 | -98.330 | -77.028 |
Tuesday, May 14, 2024 06:55 AM
BofA Securities raised the price target for the Entergy Corp. (NYSE:ETR) stock from “a Neutral” to “a Buy”. The rating was released on November 21, 2023, according to finviz. The research report from ...
|
Thursday, May 09, 2024 07:56 PM
InvestorPlace - Stock Market News, Stock Advice & Trading Tips eFFECTOR Therapeutics (NASDAQ:EFTR) just reported results for the first ...
|
Thursday, May 09, 2024 09:01 AM
SOLANA BEACH, Calif. and REDWOOD CITY, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- eFFECTOR Therapeutics, Inc. (NASDAQ: EFTR), a leader in the development of selective translation regulator inhibitors ...
|
date | open | high | low | close | volume |
---|---|---|---|---|---|
16/05/24 | 2.00 | 2.00 | 1.97 | 1.975 | 56,383 |
15/05/24 | 1.98 | 2.05 | 1.9411 | 1.98 | 111,368 |
14/05/24 | 2.01 | 2.0599 | 1.95 | 2.00 | 133,625 |
13/05/24 | 2.03 | 2.03 | 1.98 | 1.98 | 105,195 |
10/05/24 | 2.09 | 2.13 | 2.00 | 2.03 | 85,411 |
09/05/24 | 2.08 | 2.14 | 1.98 | 2.14 | 120,545 |
08/05/24 | 2.09 | 2.125 | 1.96 | 2.08 | 118,263 |
07/05/24 | 2.12 | 2.23 | 2.03 | 2.05 | 85,724 |
06/05/24 | 2.19 | 2.26 | 2.10 | 2.13 | 80,322 |
03/05/24 | 2.12 | 2.29 | 2.12 | 2.20 | 144,765 |
|
|
||||
|
|
||||
|
|